RMD Resmed Inc

  1. Stocks
  2. Healthcare
  3. NYSE: RMD

Price (delayed)

$143.655

Market cap

$21.13B

P/E Ratio

23.47

Dividend/share

$1.8

EPS

$6.12

Enterprise value

$22.48B

ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea , chronic obstructive pulmonary disease , and other respiratory ...

Highlights
The price to earnings (P/E) is 52% lower than the 5-year quarterly average of 47.2 and 40% lower than the last 4 quarters average of 37.8
RMD's equity is up by 23% year-on-year and by 5% since the previous quarter
Resmed's debt has surged by 72% YoY but it has decreased by 8% QoQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: https://www.resmed.com/
Peers: MDT TMO ELMD MASI

Key stats

What are the main financial stats of RMD
Market
Shares outstanding
147.07M
Market cap
$21.13B
Enterprise value
$22.48B
Valuations
Price to earnings (P/E)
23.47
Price to book (P/B)
5.11
Price to sales (P/S)
4.99
EV/EBIT
19.56
EV/EBITDA
16.69
EV/Sales
5.32
Earnings
Revenue
$4.22B
EBIT
$1.15B
EBITDA
$1.35B
Free cash flow
$573.63M
Per share
EPS
$6.12
Free cash flow per share
$3.91
Book value per share
$28.11
Revenue per share
$28.77
TBVPS
$23.36
Balance sheet
Total assets
$6.75B
Total liabilities
$2.62B
Debt
$1.58B
Equity
$4.13B
Working capital
$1.61B
Liquidity
Debt to equity
0.38
Current ratio
3.12
Quick ratio
1.23
Net debt/EBITDA
1
Margins
EBITDA margin
31.9%
Gross margin
55.8%
Net margin
21.3%
Operating margin
26.8%
Efficiency
Return on assets
14.2%
Return on equity
23.6%
Return on invested capital
30%
Return on capital employed
19.2%
Return on sales
27.2%
Dividend
Dividend yield
1.25%
DPS
$1.8
Payout ratio
29.4%

RMD stock price

How has the Resmed stock price performed over time
Intraday
3.88%
1 week
-0.02%
1 month
-10.76%
1 year
-33.21%
YTD
-30.98%
QTD
-34.25%

Financial performance

How have Resmed's revenue and profit performed over time
Revenue
$4.22B
Gross profit
$2.36B
Operating income
$1.13B
Net income
$897.56M
Gross margin
55.8%
Net margin
21.3%
The company's revenue rose by 18% YoY and by 5% QoQ
The gross profit has grown by 16% YoY and by 4.2% from the previous quarter
RMD's net income is up by 15% YoY and by 4% QoQ
RMD's operating income is up by 13% YoY

Growth

What is Resmed's growth rate over time

Valuation

What is Resmed stock price valuation
RMD P/E details
P/E
23.47
P/B
5.11
P/S
4.99
EV/EBIT
19.56
EV/EBITDA
16.69
EV/Sales
5.32
The price to earnings (P/E) is 52% lower than the 5-year quarterly average of 47.2 and 40% lower than the last 4 quarters average of 37.8
The EPS has increased by 15% YoY and by 3.9% from the previous quarter
RMD's P/B is 49% below its 5-year quarterly average of 9.7 and 41% below its last 4 quarters average of 8.4
RMD's equity is up by 23% year-on-year and by 5% since the previous quarter
The P/S is 43% lower than the 5-year quarterly average of 8.5 and 41% lower than the last 4 quarters average of 8.1
The company's revenue rose by 18% YoY and by 5% QoQ

Efficiency

How efficient is Resmed business performance
The company's return on invested capital fell by 22% YoY and by 4.2% QoQ
The ROA has decreased by 11% YoY and by 2.7% from the previous quarter
Resmed's ROE has decreased by 2.9% YoY

Dividends

What is RMD's dividend history
Dividend details
DPS
$1.8
Dividend yield
1.25%
Payout ratio
29.4%
Recent dividends

Financial health

How did Resmed financials performed over time
The company's total assets is 158% higher than its total liabilities
RMD's total liabilities has surged by 51% year-on-year but it is down by 6% since the previous quarter
The company's total assets rose by 32% YoY
Resmed's debt is 62% lower than its equity
Resmed's debt has surged by 72% YoY but it has decreased by 8% QoQ
Resmed's debt to equity has increased by 41% YoY but it has decreased by 14% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.